In-depth analysis of lupeol: delving into the diverse pharmacological profile
Open accessThe DOI matches its Crossref record; 266 of the 276 references it cites were found in a registry or an index.
Abstract
Lupeol, a naturally occurring lupane-type pentacyclic triterpenoid, is widely distributed in various edible vegetables, fruits, and medicinal plants. Notably, it is found in high concentrations in plants like Tamarindus indica , Allanblackia monticola , and Emblica officinalis , among others. Quantitative studies have highlighted its presence in Elm bark, Olive fruit, Aloe leaf, Ginseng oil, Mango pulp, and Japanese Pear bark. This compound is synthesized from squalene through the mevalonate pathway and can also be synthetically produced in the lab, addressing challenges in natural product synthesis. Over the past four decades, extensive research has demonstrated lupeol’s multifaceted pharmacological properties, including anti-inflammatory, antioxidant, anticancer, and antibacterial effects. Despite its significant therapeutic potential, clinical applications of lupeol have been limited by its poor water solubility and bioavailability. Recent advancements have focused on nano-based delivery systems to enhance its bioavailability, and the development of various lupeol derivatives has further amplified its bioactivity. This review provides a comprehensive overview of the latest advancements in understanding the pharmacological benefits of lupeol. It also discusses innovative strategies to improve its bioavailability, thereby enhancing its clinical efficacy. The aim is to consolidate current knowledge and stimulate further research into the therapeutic potential of lupeol and its derivatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
LPS/TLR4 signal transduction pathway
Lu, Y.-C., Yeh, W.-C., & Ohashi, P. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.01.006 · Cited by 3,301
The mechanisms of alloxan- and streptozotocin-induced diabetes
Lenzen, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0886-7 · Cited by 2,290
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Garcia, D., & Shaw, R. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.032 · Cited by 1,978
Design and production of nanoparticles formulated from nano-emulsion templates-A review
Anton, N., Benoit, J.-P., & Saulnier, P. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.007 · Cited by 1,226
Development and validation of a measure of climate change anxiety
Clayton, S., & Karazsia, B. T. (2020) · Journal of Environmental Psychology · doi:10.1016/j.jenvp.2020.101434 · Cited by 1,196
Endothelial Function: Cardiac Events
Lerman, A., & Zeiher, A. M. (2005) · Circulation · doi:10.1161/01.cir.0000153339.27064.14 · Cited by 1,096
Research works printed but not linked: 16
- Deshmukh A. S. Morankar P. G. Kumbhare M. R. (2014). Review on analgesic activity and determination methods. PhTechMed 3 (1).
- Devi S. K. Vishnpriya V. Ponnulakshmi R. Gayahtri R. Shymaladevi B. Madhan K. (2019). Lupeol regulates glucose transporter-4 and AS160 in adipose tissue of high-fat diet-fed diabetic rats. Drug Invent. Today 12 (6), 1118– 1190.
- Gayathri G. R. Krishnan M. Jayaraman S. Dhivyadharshini A. Vishnpriya V. Ponnulakshmi R. (2019a). Effect of lupeol on insulin receptor substrate-1 and AKt expression in adipose tissue of type-2 diabetic rats. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370770179.
- Gayathri G. R. Krishnan M. Jayaraman S. Jayavabhushana V. Vishnupriya V. Ponnulakshmi R. (2019b). Lupeol supplementation attenuates overexpression of sterol regulatory element-binding protein in hepatocytes: an experimental study. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370770232.
- Gayathri G. R. Krishnan M. Shreenithi S. Vishnupriya V. Ponnulakshmi R. Gayathri R. (2019c). In silico and in vivo approach to identify the antidiabetic activity of lupeol. Drug Invent. Today 11. Available at: https://www.researchgate.net/publication/370560564.
- Jayaraman S. Krishnan M. Deepika R. Selvaraj J. Vishnupriya V. Ponnulakshmi R. (2019). Effects of lupeol on insulin receptor substrate-2 and its phosphorylation in the liver of high-fat diet and sucrose-induced type-2 diabetic rats. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370769794.
- Kaviya N. E. Vishnupriya V. Ponnulakshmi R. Gayathri G. R. Krishnan M. Jayaraman S. (2019). Lupeol protects kidney from high-fat diet-induced renal damage: an experimental study. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370770959.
- Khan M. F. Maurya C. K. Dev K. Arha D. Rai A. K. Tamrakar A. K. (2014b). Design and synthesis of lupeol analogues and their glucose uptake stimulatory effect in L6 skeletal muscle cells. Bioorg. Med. Chem. Lett. 24 (12), 2674– 2679. 10.1016/j.bmcl.2014.04.059 24813738 · DOI
- Lee H.-A. Han J.-S. (2022). Facilitation of glucose uptake by lupeol through the activation of the PI3K/AKT and AMPK dependent pathways in 3T3-L1 adipocytes. J. Life Sci. 32 (2), 86– 93. 10.5352/JLS.2022.32.2.86 · doi:10.5352/jls.2022.32.2.86
- Minda D. Pavel I. Z. Borcan F. Coricovac D. Pinzaru I. Andrica F. (2015). Beneficial effects of a lupeol-cyclodextrin complex in a murine model of photochemical skin carcinoma. Rev. Chim. 66, 373– 377.
- Padmapriya N. Selvaraj J. Vishnupriya V. Ponnulakshmi R. Gayathri B. Shyamaladevi B. (2019). Effects of lupeol on insulin receptor and glucose transporter-4 in cardiac tissue of Type-2 diabetic rats. In Drug Invent. Today 12.
- Pereira Beserra F. Sérgio Gushiken L. F. Vieira A. J. Augusto Bérgamo D. Luísa Bérgamo P. Oliveira de Souza M. (2020). From inflammation to cutaneous repair: topical application of lupeol improves skin wound healing in rats by modulating the cytokine levels, NF-κB, ki-67, growth factor expression, and distribution of collagen fibers. Int. J. Mol. Sci. 21 (14), 4952. 10.3390/ijms21144952 32668794 PMC7404060 · DOI
- Pereira Beserra F. Xue M. Maia G. L. A. Leite Rozza A. Helena Pellizzon C. Jackson C. J. (2018). Lupeol, a pentacyclic triterpene, promotes migration, wound closure, and contractile effect in vitro: possible involvement of pi3k/akt and p38/erk/mapk pathways. Molecules 23 (11), 2819– 1021. 10.3390/molecules23112819 30380745 PMC6278408 · DOI
- Roitt I. Brostoff J. Male D. (2001). Immunology. 6th ed. London: Mosby.
- Tchimene M. K. Nwaehujor C. O. Ezenwali M. Okoli C. C. M Iwu M. (2016b). Free radical scavenging activity of lupeol isolated from the methanol leaf extract of Crateva adansonii oliv (capparidaceae). Int. J. Pharmacogn. Phytochemical Res. 8 (3), 419– 426.
- Tiwari A. Gandhi S. Joshi M. (2019). Effect of lupeol in diabetic nephropathy and its anti-oxidant mechanism. Int. J. Adv. Sci. Technol. 28 (20), 1404– 1413.
Cited by
ALMOUSA, L. A., Pandey, P., Lakhanpal, S., Kyada, A., Malathi, H., Nayak, P. P., Hussain, A., Hasan, T. N., Alagal, R. I., & Khan, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1594901 · Cited by 29
Broad‐Spectrum Therapeutic Potentials of the Multifaceted Triterpene Lupeol and Its Derivatives
Parvez, A., Rahman, M. A., Rahman, M. M., Shimki, A. I., Ahmmed, S., Supti, F. A., Hasan, M. H., Bristi, M. S. A., Ansari, S. A., & Islam, M. T. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402286 · Cited by 15
“%) at elevated concentrations [30] Wounds healing in diabetic patients Streptozotocin-induced hyperglycemic rats (male Sprague-Dawley) 0.2% w/w lupeol cream using a 2-cm diameter punch daily for 14 days (topically) Elevated levels of superoxide dismutase-2 and heme oxygenase-1 as a result of…”
InfluentialFilip, S., & Đurović, S. D. (2025) · Flavour and Fragrance Journal · doi:10.1002/ffj.3872 · Cited by 5
Kouvourbe, K., Waleguele, C. C., Nguekeu, Y. M. M., Temgoua, E. V. N., Matheuda, E. G., Matchide, M. G. T., Tchuenmogne, M. A. T., Nanfack, A. R. D., Kodama, T., Anthonissen, S., et al. (2025) · Biochemical Systematics and Ecology · doi:10.1016/j.bse.2025.104991 · Cited by 4
SOCACIU, M. A., Diaconeasa, Z. M., Rugină, D. O., Socaciu, C., Moldovan, R., & Clichici, S. V. (2025) · Biomolecules · doi:10.3390/biom16010025 · Cited by 5
Lupeol acetate from Cleome viscosa as a therapeutic candidate for myocardial infarction
Diokadan, J., Divine, I. A., Emma, S., Makiwa, R. S., Celine, U., Nicholus, L., Ronald, S. B., Kosanam, S., & Pasupula, R. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00383-9 · Cited by 3
AlSedairy, S. A., Binobead, M. A., Alanazi, F., & Aziz, I. M. (2026) · Biomedicines · doi:10.3390/biomedicines14010121 · Cited by 4
In situ Ca²⁺‑cross‑linking effects on pectin–tragacanth films for fresh raspberry preservation
Dobrucka, R., Vápenka, L., Pawlik, M., & Szymański, M. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115507 · Cited by 6
Signaling pathways and molecular mechanisms of lupeol in colorectal cancer: A comprehensive review
Farooqi, M. A., & Sahu, K. K. (2026) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2025.101270 · Cited by 3
“Moreover, integrating lupeol into combination therapies with existing chemotherapeutic agents like 5-fluorouracil (5-FU) can enhance its efficacy, reduce resistance, and lower the toxicity associated with standard treatments [76].”
Nakov, K., Gething, M. E., Kassis, T. K., Rutt, G. J., Ho, B., Bhandari, N., Collignon, T. E., Banerjee, S., & Bishayee, A. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109014 · Cited by 3
Kaya, C., Kapısız, A., Eryılmaz, S., Karabulut, R., Türkyılmaz, Z., İnan, M. A., Aydin, G. Y., Celik, M., & Sönmez, K. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s501289 · Cited by 1
Shafqat, A., Siddiqua, A., Akram, W., Kazmi, A., Altalhi, A., Akthar, S., & Ambreen, M. (2025) · Journal of Basic Microbiology · doi:10.1002/jobm.70121 · Cited by 2
“Lupeol, in particular, has been reported to possess anti ‐ inflammatory, antimicrobial, and antiproliferative activities [48], suggesting its potential role in enhancing plant defense responses.”
Anyanwu, E. G., Onuchukwu, C. L., Ojukwu, C. P., & Anyanwu, C. N. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121293 · Cited by 1
Dobrucka, R., & Szymański, M. (2026) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2026.112732 · Cited by 1
Raj, A., Ashrafi, S., Hossain, M. S., Islam, M. S., Al-Mansur, M. A., Ihsan, A. B., Kuddus, M. R., & Ahmed, F. (2026) · BioMed Research International · doi:10.1155/bmri/4730586 · Cited by 1
“This pattern is pharmacologically plausible because both lupeol-and betulin-type scaffolds have repeatedly been associated with anti-inflammatory activity in recent preclinical literature [48, 49].”
Kolanchi, P., Annathurai, A., Murugan, M., Shanmugam, P. S., Srinivasan, T., Alagar, M., Suganthi, A., & Krishnamoorthi, P. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71563 · Cited by 1
“Their cooccurrence suggests possible biochemical coordination, balancing cytotoxic effects on cell membranes with mechanisms that stabilize cells and modulate immune responses [22, 23].”
Wei, Y., Lu, G., Zhang, G., Wang, Y., & Luo, P. (2025) · Journal of Mass Spectrometry · doi:10.1002/jms.5169
Mussa, S. S., Kingori, D. G., Kefa, B. K., Felix, O., Boro, K. W., Muiruri, I. N., Musyoka, T. M., & Njagi, E. N. M. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120673 · Cited by 2
Lohik, M. N., Bilanda, D. C., Owona, P. E., Kengne, S. F., MENGUE, Y. S. N., Ambamba, B. D. A., Tcheutchoua, Y. C., Goufani, R. B. A., Malane, A. E. R. N., Percevault, F., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121322
Jatoth, R., Dhanabal, S., Venkatachalam, S., Ganesh, T., & Potti, L. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.100960
Neuroprotective effect of lupeol in animal model of D-galactose induced cognitive dysfunction
Kapil, O., Rawat, A. D., Sharma, D., Akhilesh, Mahapatra, A., Sunkaria, A., & Tiwari, V. (2025) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqaf013
Bailly, C. (2026) · Life · doi:10.3390/life16020358
“However, in the terpenoid group, the main product of interest is lupeol, for which innovative strategies to improve its bioavailability have already been deployed with the objective of enhancing its clinical efficacy [114,209,210].”
Dhiman, S., Sharma, P., Rana, J., & Sehgal, A. K. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100788
Setyowati, E. P., Utami, D. T., Haryanti, S., Syahputra, R. A., Dalimunthe, A., Harahap, Y., & Kim, B. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00095
Self-citationBoonruang, K., Nilkhet, S., Kim, T. E., Krisanapun, C., Kim, S.-K., Ryu, J., & Baek, S. J. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124644
Sabuz, Ó., Folz, J. S., Deepika, D., Blanco, J., Schuhmacher, M., Aichinger, G., & Kumar, V. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00516
Regulation of the Apoptotic Modulatory Pathway During Eimeriosis by Cassia alata Extract
Elshershaby, R. E., Dkhil, M. A., DAR, Y., THAGFAN, F. A., Abdel‐Gaber, R., Helal, I. B., & Bakr, L. (2026) · Current Microbiology · doi:10.1007/s00284-026-04924-z
“In addition, triterpenes and sterols such as squa - lene, γ-sitosterol, and lupeol further enhance the bioactiv - ity profile through potent antioxidant, anti-inflammatory, antiapoptotic, and anticancer actions [30, 31, 32].”
Ojugbeli, E. T., Onobrudu, D. A., Awhin, P. E., Enemuwe, I. M., Uzuegbu, U. E., Opajobi, A. O., Acha, J. O., & Onyesom, I. (2026) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v10i4.19
Shahid, H., Flood, J. P., Li, F., Zhou, X., Münch, G. W., & Raju, R. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050495
“…[26], demethoxysudachitin ( 3 ) [27], hispidulin ( 4 ) [28,29], herbacetin 3,7,8-trimethyl ether ( 5 ) [30,31], genkwanin ( 6 ) [32,33], siegeskaurolic acid ( 7 ) [34], fritillebic acid ( 8 ) [35], kaurenoic acid ( 9 ) [36], lup-20(29)-ene-3 β , 16 β -diol ( 10 ) [37,38], and lupeol ( 11 ) [39,40].”
Yuvraj, S., Shetti, P. P., & Maroor, T. P. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.101002
Purwar, S., Verma, A., Jaiswal, R. P., Mishra, V., Chugh, V., SINGH, C. M., Azam, A., Kumar, N., Upadhyay, P., Chaubey, T., et al. (2026) · Molecules · doi:10.3390/molecules31111977
Rayshan, A. R., & Azman, K. F. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119673
Applications of lupeol to manage fungal infections: a promising multi-target molecule
Araújo, G. D. S., Fonseca, X. M. Q. C., Silva, R. N. A. L., Guedes, G. M. D. M., Sidrim, J. J. C., Cordeiro, R. D. A., Riello, G. B. C., Pereira, V. C., Castelo‐Branco, D. D. S. C. M., & Rocha, M. F. G. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2691665
Qahtan, A. A., Alatar, A. A., Alobaidi, A. S., & Faisal, M. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_1738_2025
Jorge, I., Guibunda, G., Amade, J. A., Rosa, P. A. N., Diogo, J., Hodela, G., Dique, A. S., Cuinica, L. G., & Ernesto, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10337073/v1
Thokchom, B., Bhavi, S. M., Padti, A. C., Singh, S. R., Abbigeri, M. B., Kulkarni, S. R., Moses, S., R., S. L. S., Harshini Raj, S., R., S. H., et al. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71549
Nipa, F. A., AHMED, P., Majumder, S., Joy, M. M. I. S., Mohajan, S., Chowdhury, S., Fahim, M. T. H., Dutta, M., Khalil, M. E., Wahab, I. B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10568437/v1
Zhang, L., Chen, X., Wu, H., Wang, W., Zhang, J., & Shen, P. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110355
Ahmed, Z., Adib, M., Ashrafi, S., Islam, M. S., Al-Mamun, M. R., & Ahsan, M. (2026) · Journal of Food Biochemistry · doi:10.1155/jfbc/4312846
Gao, H., Yang, Y., Han, B., Ren, M., & Yang, Y. (2026) · Archaeometry · doi:10.1111/arcm.70206
Aziz, I. M., Alshalan, R. M., & Aljowaie, R. M. (2026) · Pharmaceuticals · doi:10.3390/ph19091330
“…-cyclopenta[a]phenanthren-3-ol and ( 1R , 3aR , 5aR , 5bR , 7aR , 9S , 11aR , 11bR , 13aR , 13bR )-3a,5a,5b,8,8,11a-Hexamethyl-1-(prop-1-en-2-yl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol, have anticancer and anti-inflammatory properties [13–16].”
Singh, S., Singh, R., Srivastava, S., Katara, P., Nigam, A. K., Yadav, A. B., & Gour, J. K. (2026) · 3 Biotech · doi:10.1007/s13205-026-05032-2
“It has been reported to inhibit DNA topoisom - erase IIα/β (Mitaine-Offer et al. 2002; Zhou et al. 2024) and human neutrophil elastase (Dalimunthe et al. 2024; Saleem 2009), highlighting its broad pharmacological potential and supporting its predicted safety profile.”
Vinodkumar, T., Jesuraj, P. N., Hariharan, A., Dinesh, T., Narasimhaji, C. V., Ghosh, K., Kusuma, G., Swamy, C. T., Kumar, P., Chitra, S., et al. (2026) · ChemistrySelect · doi:10.1002/slct.74559
Hamza, M., Samanta, S., Khan, M. F., Roy, S., Fatima, Z., Gupta, R., Gallo, S., & Srivastava, N. (2026) · Gels · doi:10.3390/gels12100918
Ainyanbhor, I. E., Olumese, F. E., Onoagbe, I. O., & Edo, G. I. (2026) · Next research. · doi:10.1016/j.nexres.2026.102588
Cheng, K.-L., Mao, G., Yin, Z., Ye, X., Sun, C., Zhou, X., & Zhang, T. (2026) · Journal of the American Oil Chemists Society · doi:10.1002/aocs.70170
Castiglione, D., Nardi, A., Fontana, G., Badalamenti, N., & Pace, V. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00649
Hossain, M. G., Adcock, J. L., & Callahan, D. L. (2026) · Bioresources and Bioproducts · doi:10.3390/bioresourbioprod2040024
Khan, M. I. A., Khan, I. A., Malik, A., Malik, M., Khan, V., Rehman, A., Anjum, A., Khan, M. K., Ghauri, Q. A., Junaid, M., et al. (2026) · Biomarker Insights · doi:10.1177/11772719261502039
Metadata
- Authors
- Dalimunthe, A., Carensia Gunawan, M., Dhiya Utari, Z., Dinata, M. R., Halim, P., Estherina S. Pakpahan, N., Sitohang, A. I., Sukarno, M. A., Yuandani, Harahap, Y., Setyowati, E. P., Park, M. N., Yusoff, S. D., Zainalabidin, S., Prananda, A. T., Mahadi, M. K., Kim, B., Harahap, U., & Syahputra, R. A.
- Affiliations
- Universitas Sumatera Utara (ID)
- University of Indonesia (ID)
- Universitas Gadjah Mada (ID)
- Kyung Hee University (KR)
- National University of Malaysia (MY)
- Corresponding author
- Syahputra, Rony Abdi
- ORCID
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2024-11-13
- Volume
- 15
- Pages
- 1461478-1461478
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC11598436
- OpenAlex
- W4404340059
- Cited by
- 50
- References
- 276
- Citations by year
- 2026: 39 · 2025: 11
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation (2020R1I1A2066868, 2020R1A5A2019413)
- Kyung Hee University (KHU-20230914, 20230914)
- Korea Health Industry Development Institute (HF20C0038, NRF-2020R1I1A2066868)
- National Research Foundation of Korea (2020-R1A5A2019413, 2020R1I1A2066868, NRF-2020R1I1A2066868)
- Universitas Sumatera Utara
- Ministry of Science and ICT, South Korea (2022-IT-RD-0205, 2022-IT-RD-0205-01-101, 2020R1A5A2019413)
- National Institute of Environmental Health Sciences (27302C0038)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Phytochemical Studies and Bioactivities
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- lupeol, pentacyclic triterpenes, lupane triterpenoids, pharmacological properties, anti-inflammatory activity, antioxidant activity, anticancer activity, antibacterial activity, bioavailability enhancement, nanoparticle drug delivery, lupeol derivatives, squalene, mevalonate pathway, medicinal plants
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.